Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma

NCT00003719 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: irinotecan hydrochloride

Sponsor

Herbert Irving Comprehensive Cancer Center